Literature DB >> 24695909

Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.

C Martinez1, A T Cohen, L Bamber, S Rietbrock.   

Abstract

Contemporary data from population studies on the incidence and complications of venous thromboembolism (VTE) are limited. An observational cohort study was undertaken to estimate the incidence of first and recurrent VTE. The cohort was identified from all patients in the UK Clinical Practice Research Datalink (CPRD) with additional linked information on hospitalisation and cause of death. Between 2001 and 2011, patients with first VTE were identified and the subset without active cancer-related VTE observed for up to 10 years for recurrent VTE. The 10-year cumulative incidence rates (CIR) were derived with adjustment for mortality as a competing risk event. A total of 35,373 first VTE events (12,073 provoked, 16,708 unprovoked and 6592 active cancer-associated VTE) among 26.9 million person-years of observation were identified. The overall incidence rate (IR) of VTE was 131.5 (95% CI, 130.2-132.9) per 100,000 person-years and 107.0 (95% CI, 105.8-108.2) after excluding cancer-associated VTE. DVT was more common in the young and PE was more common in the elderly. VTE recurrence occurred in 3671 (CIR 25.2%). The IR for recurrence peaked in the first six months at around 11 per 100 person years. It levelled out after three years and then remained at around 2 per 100 person years from year 4-10 of follow-up. The IRs for recurrences were particularly high in young men. In conclusion, VTE is common and associated with high recurrence rates. Effort is required to prevent VTE and to reduce recurrences.

Entities:  

Keywords:  Thrombosis; deep-vein thrombosis; pulmonary embolism

Mesh:

Year:  2014        PMID: 24695909     DOI: 10.1160/TH13-09-0793

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  40 in total

Review 1.  Breadth of complications of long-term oral anticoagulant care.

Authors:  Walter Ageno; Marco Donadini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Reduction in physical function in women after venous thromboembolism.

Authors:  K A Hagan; L B Harrington; J Kim; O Zeleznik; E B Rimm; F Grodstein; C Kabrhel
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

3.  Is there a role for low-dose DOACs as prophylaxis?

Authors:  Alexander T Cohen; Beverley J Hunt
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.

Authors:  Charlotte A Bradbury; Zoe Craig; Gordon Cook; Charlotte Pawlyn; David A Cairns; Anna Hockaday; Andrea Paterson; Matthew W Jenner; John R Jones; Mark T Drayson; Roger G Owen; Martin F Kaiser; Walter M Gregory; Faith E Davies; J Anthony Child; Gareth J Morgan; Graham H Jackson
Journal:  Blood       Date:  2020-08-27       Impact factor: 22.113

5.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

6.  Epidemiology of venous thromboembolism in the Framingham Heart Study.

Authors:  Marja K Puurunen; Philimon N Gona; Martin G Larson; Joanne M Murabito; Jared W Magnani; Christopher J O'Donnell
Journal:  Thromb Res       Date:  2016-06-29       Impact factor: 3.944

7.  Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism.

Authors:  Parth Patel; Payal Patel; Meha Bhatt; Cody Braun; Housne Begum; Wojtek Wiercioch; Jamie Varghese; David Wooldridge; Hani Alturkmani; Merrill Thomas; Mariam Baig; Waled Bahaj; Rasha Khatib; Rohan Kehar; Rakesh Ponnapureddy; Anchal Sethi; Ahmad Mustafa; Wendy Lim; Grégoire Le Gal; Shannon M Bates; Linda B Haramati; Jeffrey Kline; Eddy Lang; Marc Righini; Mohamad A Kalot; Nedaa M Husainat; Yazan Nayif Al Jabiri; Holger J Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2020-09-22

Review 8.  Drug Treatment of Venous Thromboembolism in the Elderly.

Authors:  Jir Ping Boey; Alexander Gallus
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

9.  Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage.

Authors:  Walter Bialkowski; Sylvia Tan; Alan E Mast; Joseph E Kiss; Daryl Kor; Jerome Gottschall; Yanyun Wu; Nareg Roubinian; Darrell Triulzi; Steve Kleinman; Young Choi; Donald Brambilla; Ann Zimrin
Journal:  Thromb Res       Date:  2019-11-25       Impact factor: 3.944

10.  Association of interleukin-18 gene polymorphism and its protein expression with the lower extremity deep venous thrombosis in the chinese han population: A case-control study.

Authors:  Ye-Long Chen; Li-Hong Shou; Zong-Xin Zhang
Journal:  J Clin Lab Anal       Date:  2017-11-04       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.